169244 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses; Bacteria Mycobacteria
ASSAYS FOR ANTIMICROBIAL ACTIVITY AND APPLICATIONS THEREOF
#2MONOCLONAL ANTIBODIES TO ARABINOMANNAN (AM), GROEL2, AND LPRG AND METHODS OF USE
#3Sample Collection and Analysis
#4MYCOBACTERIUM TUBERCULOSIS PROTEINS IN DIAGNOSTIC ASSAYS AND DEVICES FOR TUBERCULOSIS DETECTION AND DIAGNOSIS
#5IDENTIFICATION OF A NEW POTENT INHIBITOR OF MYCOBACTERIAL GROWTH
#6CU GROWTH ENHANCED PLASMONIC ASSAY FOR ISOLATION-FREE EXOSOME ANALYSIS
#7IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
#8BIOMARKERS FOR MYCOBACTERIUM BOVIS
#9PHOSPHATIDYLSERINE TARGETING MOLECULE COMBINED WITH MEMORY T CELL ANTIGEN FOR THERAPEUTIC, DIAGNOSTIC AND ADJUVANT USE
#10COMBINATION ASSAY OF CYTOKINES AND HUMAN ANTIBODIES TO MAP FOR THE DIAGNOSIS OF CROHNS DISEASE, TUBERCULOSIS, AND OTHER BACTERIAL DISEASES
#11METHOD FOR DETECTING AN IMMUNE CELLULAR RESPONSE
#12COMPOSITIONS AND METHODS FOR HIP1-TARGETING INHIBITOR COMPOUNDS
#13MICELLAR MYCOLATE COATED CARBON ELECTRODES FOR ELECTROCHEMICAL IMPEDANCE IMMUNOASSAY
#14USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM
#15METHOD OF DETECTING AND IDENTIFYING A MICROORGANISM
#16BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
#17Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections
#18Tuberculosis detection kit
#19Kit for detecting drug-resistant tuberculosis
#20ANTIGENIC TRIPEPTIDES DERIVED FROM MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS S-TYPE STRAINS, DERIVATIVES AND USES THEREOF
#21TRANSKETOLASE EPITOPES, METHODS, AND DEVICES FOR IGG-BASED TUBERCULOSIS SERODIAGNOSIS
#22DEVICE TO DETECT AIRBORNE PATHOGENS
#23MYCOBACTERIUM TUBERCULOSIS COMPOSITIONS AND METHODS
#24DIAGNOSTIC METHOD FOR INFECTIOUS DISEASES
#25IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
#26BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
#27MONOCLONAL ANTIBODIES AND USES THEREOF
#28High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody
#29USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN
#30PROTEIN BIOMARKER AND USES THEREOF
#31CLICK CHEMISTRY AMPLIFIED NANOPORE ASSAY FOR ULTRASENSITIVE QUANTIFICATION OF PROTEINS
#32BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS
#33Method of detecting subspecies paratuberculosis infection
#34High-affinity capsule-specific human monoclonal antibody
#35Serum metabolic biomarkers for detecting tuberculosis and tuberculosis detection kit
#36SERUM METABOLIC BIOMARKERS AND KIT FOR DETECTING DRUG-RESISTANT TUBERCULOSIS
#37Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#38IMMUNOCHROMATOGRAPHIC KIT AND METHOD FOR DETECTING MYCOBACTERIUM TUBERCULOSIS
#39CONCENTRATION DEVICE, SAMPLE SOLUTION CONCENTRATION METHOD, SAMPLE SOLUTION EXAMINATION METHOD, AND EXAMINATION KIT
#40SAMPLE SOLUTION CONCENTRATION METHOD AND SAMPLE SOLUTION EXAMINATION METHOD
#41COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND DIAGNOSING MYCOBACTERIAL INFECTIONS
#42METHOD OF DETECTING TB IN BLOOD SAMPLE
#43Chimeric polyprotein for vaccines and diagnostics
#44IN VITRO METHOD FOR DIAGNOSING SUBJECTS INFECTED WITH MYCOBACTERIUM SPECIES
#45COMPOSITIONS AND METHODS OF DIAGNOSING AND TREATING TUBERCULOSIS
#46Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#47METHODS OF DETECTING LIPOARABINOMANNAN AND DIAGNOSING NONTUBERCULOSIS MYCOBACTERIAL INFECTION
#48METHODS AND COMPOSITIONS FOR DIAGNOSIS OF TUBERCULOSIS
#49Sample Collection and Analysis
#50METHODS FOR THE DIAGNOSIS OF BURULI ULCER
#51BOVINE PATHOGEN ARRAY
#52VACCINE
#53METHODS FOR ASSESSING THE RISK OF DEVELOPING ACTIVE TUBERCULOSIS
#54Apparatus and Method for Testing the Health Condition of Animals and/or Human Beings
#55COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUBERCULOSIS
#56IN VITRO METHOD FOR DISCRIMINATING LATENT FROM ACTIVE TUBERCULOSIS
#57DIAGNOSTIC REAGENT
#58DIAGNOSTIC REAGENTS
#59METHOD FOR DETECTING OR MONITORING THE PROGRESSION OF A CHRONIC AUTOIMMUNE DISEASE BY IMMUNOASSAY
#60Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections
#61Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#62ASSAYS FOR ANTIMICROBIAL ACTIVITY AND APPLICATIONS THEREOF
#63Method of detecting subspecies
#64NITROCELLULOSE SHEET COMPRISING IMMOBILIZED IMMUNOGLOBULINS AND LIPID BASED ANTIGENS AND USE THEREOF
#65BIOMARKERS
#66METHOD OF DETECTING CANCER AND/OR TUBERCULOSIS
#67Immunogenic compositions comprising polypeptides and fusions thereof
#68Tuberculosis diagnosis method and apparatus therefor
#69METHODS AND COMPOUND FOR THE IDENTIFICATION AND TREATMENT OF TUBERCULOSIS
#70AN INTEGRATED MICROFLUIDIC ELECTRODE ARRAY SYSTEM FOR ENZYME-LINKED IMMUNO-SORBENT ASSAY (EASY-ELISA) FOR POINT-OF-CARE DETECTION OF MOLECULAR AND CELLULAR BIOMARKERS
#71RAPID DIAGNOSTICS OF MYCOBACTERIA WITH LECTIN CONJUGATED PARTICLES
#72METHODS FOR DUAL DETECTION AND DIFFERENTIATION OF INFECTION BY MYCOBACTERIUM TUBERCULOSIS COMPLEX AND NONTUBERCULOUS MYCOBACTERIA
#73Synthetic antigens for tuberculosis detection
#74IDENTIFICATION OF METABOLOMIC SIGNATURES IN URINE SAMPLES FOR TUBERCULOSIS DIAGNOSIS
#75IMMUNOCHROMATOGRAPHIC KIT AND METHOD FOR DETECTING MYCOBACTERIUM TUBERCULOSIS
#76Global gene regulators (GGR) as vaccine candidates against
#77IMMUNOGENIC PEPTIDES AND USE THEREOF
#78Biomarkers for early diagnosis and differentiation of mycobacterial infection
#79METHOD
#80Methods and kits for determining tuberculosis infection status
#81HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY
#82Simultaneous Parallel Signal Amplification and Analyte-Ligand Capture Functions
#83High-affinity capsule-specific human monoclonal antibody
#84Anti-PD-L1 antibody for detecting PD-L1
#85Method and associated device for rapid detection of target biomolecules with enhanced sensitivity
#86Device for rapid detection of tuberculosis-lipoarabinomannan (TB-LAM) with enhanced sensitivity
#87ANTIBODY OR ANTIBODY COMBINATION AND METHOD USING SAME FOR DETECTION OF AN ANTIGEN RELATED TO MYCOBACTERIUM IN A URINE SAMPLE OF A SUBJECT
#88SYSTEMS AND METHODS TO DIAGNOSE SARCOIDOSIS AND IDENTIFY MARKERS OF THE CONDITION
#89CD153 AND/OR CD30 IN INFECTION
#90COMPOSITIONS AND METHODS FOR DETECTING MYCOBACTERIUM TUBERCULOSIS
#91DNA aptamer specifically binding to TB7.7, and use thereof
#92Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#93AUTOMATED IMMUNOANALYZER SYSTEM FOR PERFORMING DIAGNOSTIC ASSAYS FOR AUTOIMMUNE AND INFECTIOUS DISEASES
#94MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS IMMUNODIAGNOSTIC ANTIGENS, METHODS, AND KITS COMPRISING SAME
#95DNA aptamer specifically binding to ESAT6, and use thereof
#96DNA aptamer specifically binding to CFP10, and use thereof
#97METHODS FOR MONITORING TUBERCULOSIS MEDICATION
#98Detection of analytes using live cells
#99Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections
#100Anti-C3d antibody conjugates and methods of detecting complement activation
#101Assays for antimicrobial activity and applications thereof
#102Chimeric M. hyorhinis polyprotein for vaccines and diagnostics
#103Method for detecting an immune cellular response
#104Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#105METHODS AND COMPOSITIONS FOR QUANTIFYING EXOSOMES
#106Method of diagnosing tuberculosis
#107Protein biomarker and uses thereof
#108Method and system for detection of mycobacteria in human samples
#109Biomarkers for early diagnosis and differentiation of mycobacterial infection
#110ANTIBODIES DIRECTED AGAINST SIGNAL PEPTIDES, METHODS AND USES THEREOF
#111DIAGNOSTIC
#112Anti-PD-L1 antibody for detecting PD-L1
#113Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#114Methods of Detecting and Diagnosing Tuberculosis Using Anti-MTLDL Antibodies
#115Device, system method and kit for isolating an analyte from a body fluid sample
#116Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#117METHOD FOR REMOVING INHIBITORY COMPONENTS
#118METHOD FOR DETECTING THE PRESENCE OF MYCOBACTERIAL MATERIAL IN SAMPLE USING IMMOBILISED MANNOSYL PHOSPHOKETIDE ANTIGEN
#119MYCOBACTERIUM TUBERCULOSIS PROTEINS IN DIAGNOSTIC ASSAYS AND DEVICES FOR TUBERCULOSIS DETECTION AND DIAGNOSIS
#120Biomarkers of latent tuberculosis infection
#121Methods for the detection of a latent tuberculosis infection
#122Method for detecting the presence of mycobacterial material in a sample using at least two antigens
#123Method and associated device for rapid detection of target biomolecules with enhanced sensitivity
#124Device for rapid detection of tuberculosis-lipoarabinomannan (TB-LAM) with enhanced sensitivity
#125ANTIBODIES DIRECTED AGAINST SIGNAL PEPTIDES, METHODS AND USES THEREOF
#126antigens
#127MATERIALS AND METHODS RELATING TO ANTIBODY TARGETS FOR TUBERCULOSIS SEROLOGY
#128SYSTEMS AND METHODS FOR EVALUATING INTERSTITIAL FLUIDS
#129Assays and methods for detecting mycobacterial infections
#130METHOD OF DIVERTING THE FIRST FRACTION OF SAMPLE AWAY FROM A LATERAL FLOW ASSAY
#131Method for measuring protein and nucleic acid with ultrahigh sensitivity
#132Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
#133TB BIOMARKERS
#134Systems and methods to diagnose sarcoidosis and identify markers of the condition
#135Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections
#136specific peptides for detection of infection or immunization in non-human primates
#137Method And Kit For Diagnosis Of Active Tuberculosis
#138Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
#139BIOMARKERS FOR DETECTION OF TUBERCULOSIS RISK
#140Compositions useful in the diagnostic of latently infected
#141CORE ELEMENTS FOR POINT OF CARE DIAGNOSIS OF TUBERCULOSIS
#142Methods and kits for determining tuberculosis infection status
#143Biomarkers for early diagnosis and differentiation of mycobacterial infection
#144BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
#145METHOD AND DEVICE FOR COLLECTING MYCOBACTERIUM COMPLEX SPECIES FROM TEH ORAL CAVITY OF A PATIENT
#146Method and kit for immunological detection of
#147Compositions and methods
#148Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#149TUBERCULOSIS BIOMARKERS AND USES THEREOF
#150Immunogenic compositions comprising polypeptides and fusions thereof
#151Methods and compositions for obtaining a tuberculosis assessment in a subject
#152Peptides of for a screening test for HIV positive patients at high-risk for tuberculosis
#153Tuberculosis biomarkers and uses thereof
#154Lateral flow assays with thermal contrast readers
#155NOVEL DESIGN OF ENZYME-LINKED IMMUNOSORBENT ASSAY PLATES AND SYSTEMS AND METHODS OF USE THEREOF
#156Methods for culture and identification of mycrobacterium avium subspecies in crohn's disease
#157Mycobacterial antigen composition
#158Tuberculosis vaccine compositions and related methods
#159METHODS OF DETECTING ANALYTES AND DIAGNOSING TUBERCULOSIS
#160Culture Medium for In-Vitro Cultivation of Mycobacterium Leprae (M. Leprae)
#161Device and associated methods for performing luminescence and fluorescence measurements of a sample
#162Device and associated methods for performing luminescence and fluorescence measurements of a sample
#163Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
#164Assays for antimicrobial activity and applications thereof
#165Detection of analytes using live cells
#166Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
#167Global gene regulators (GGR) as vaccine candidates against
#168Mycobacterium Antigens
#169METHODS AND COMPOSITIONS FOR OBTAINING A TUBERCULOSIS ASSESSMENT IN A SUBJECT
#170KIT AND METHOD
#171Method and kit for detection of mycobacteria
#172proteins
#173Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#174Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#175Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#176Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
#177Diagnostic reagents
#178Compositions and methods for immunodominant antigens
#179Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#180Specific and unique T cell responses and molecular signatures for the treatment and diagnosis of
#181Methods for producing an immune response to tuberculosis
#182Compositions and methods for immunodominant antigens of
#183METHODS FOR CULTURE AND IDENTIFICATION OF MYCROBACTERIUM AVIUM SUBSPECIES IN CROHN'S DISEASE
#184Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis
#185Methods of diagnosing and treating active tuberculosis in an individual
#186Nucleotide sequences, nucleic acid sensors and methods thereof
#187MYCOBACTERIAL ANTIGEN COMPOSITION
#188specific peptides for detection of infection or immunization in non-human primates
#189METHOD OF TREATING TUBERCULOSIS
#190biomarkers and methods
#191Mycobacterial antigen composition
#192Method and kit for immunological detection of complex
#193Biomarkers for (MAP)
#194Methods and kits for determining tuberculosis infection status
#195Diagnosis and treatment of mycobacteria infections
#196Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#197Methods and systems for determining infection
#198Tuberculosis biomarkers and uses thereof
#199Mycobacterium antigens
#200Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
#201Assays for antimicrobial activity and applications thereof
#202Biomarkers for early diagnosis and differentiation of mycobacterial infection
#203METHODS FOR DETECTING A MYCOBACTERIUM TUBERCULOSIS INFECTION
#204Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody
#205FUIDI HERD MANAGEMENT AND RISK STRATIFICATION METHODS
#206Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#207Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
#208DIAGNOSIS OF TUBERCULOSIS
#209RAPID DETECTION AND QUANTITATION OF PATHOGEN-SPECIFIC BIOMARKERS USING NANOPOROUS DUAL- OR MULTI-LAYER SILICA FILMS
#210Serologic test for the rapid diagnosis of active tuberculosis
#211Point of care assays to detect the status of tuberculosis infection
#212Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections
#213TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#214METHODS FOR DETECTING A MYCOBACTERIUM TUBERCULOSIS INFECTION
#215FUIDI HERD MANAGEMENT AND RISK STRATIFICATION METHODS
#216Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#217Methods for producing an immune response to tuberculosis
#218Sample collection and analysis
#219Compositions and methods for immunodominant antigens of
#220Methods and devices for tuberculosis diagnosis using biomarker profiles
#221Method for diagnosing tuberculosis disease by detecting induced markers after stimulation of T-cells with antigens
#222Composition for use in mycobacteria diagnosis
#223Nitrite-reductase (NIRB) as potential anti-tubercular target and a method to detect the severity of tuberculosis disease
#224Liposomal composition comprising a sterol-modified lipid and a purified mycobacterial lipid cell wall component and its use in the diagnosis of tuberculosis
#225Portable rapid diagnostic test reader and methods of using the same
#226Methods of using isotopically labelled isoniazid for the diagnosis of mycobacterial infections
#227In-vitro process for the quick determination of a patient's status relating to infection with
#228DIAGNOSTIC REAGENTS
#229Method and kit for immunological detection of
#230Dual path immunoassay device
#231Diagnostic test for infectious diseases in cattle
#232Detecting latent tuberculosis infections
#233Porous film microfluidic device for automatic surface plasmon resonance quantitative analysis
#234METHOD OF DETECTING ACTIVE TB
#235Diagnosis of tuberculosis
#236Biomarkers for Tuberculosis and HIV/AIDS
#237Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
#238Using Adaptive Immunity to Detect Drug Resistance
#239METHODS AND KITS FOR DIAGNOSING LATENT TUBERCULOSIS INFECTION
#240VACCINE FOR THE TREATMENT OF MYCOBATERIUM RELATED DISORDERS
#241Flow cytometry assay methods
#242Method of detecting and/or quantifying an analyte in a biological sample
#243Mycobacterium antigens
#244Biomarkers for detecting the presence of bacteria
#245Global gene regulators (GGR) as vaccine candidates against paratuberculosis
#246USE OF MYCOBACTERIUM AVIUM PARATUBERCULOSIS PEPTIDES TO DIAGNOSE TYPE 1 DIABETES
#247Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
#248Diagnosis method of active tuberculosis
#249Antibodies directed against signal peptides, methods and uses thereof
#250Methods for pathogen detection and disease treatment
#251Compositions and methods for detecting mycobacterium
#252Tuberculosis Biomarkers and Uses Thereof
#253Method for determining the presence or absence of a biomarker
#254Fuidi herd management and risk stratification methods
#255DEVICE, METHOD AND KIT FOR THE DETECTION OF DIFFERENT MARKERS IN DIFFERENT CELLULAR OR MOLECULAR TYPES AND THEIR QUANTIFICATIONS
#256Exosomes and diagnostic biomarkers
#257METHOD FOR GENERATING, STORING, TRANSPORTING, ELUTING AND DETECTING CLINICAL RELEVANT INFORMATION IN PLASMA USING FILTER PAPER
#258Method for determining exposure to mycobacteria
#259Dual path immunoassay device
#260MYCOBACTERIUM TUBERCULOSIS ANTIGENS AND COMBINATIONS THEREOF HAVING HIGH SEROREACTIVITY
#261Methods for differentiating between disease states
#262Tuberculosis diagnostic test
#263Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
#264Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#265Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
#266Immunogenic compositions comprising polypeptides and fusions thereof
#267FUIDI HERD MANAGEMENT SCHEMA
#268DIAGNOSTIC REAGENTS
#269Portable rapid diagnostic test reader
#270Method for determining the presence of an analyte by means of small magnetic particles, and corresponding device
#271Method of detecting surrogate markers in a serum sample
#272FUIDI HERD MANAGEMENT SCHEMA
#273Method for the diagnosis of tuberculosis
#274Methods for detecting a infection
#275Imaging method using magnetic small particles and corresponding device
#276COMPOUNDS AND METHODS FOR DIAGNOSIS AND IMMUNOTHERAPY OF TUBERCULOSIS
#277Methods for detecting antigens
#278Methods for detecting a mycobacterium tuberculosis infection
#279Tuberculosis diagnostic test
#280Methods for producing an immune response to tuberculosis
#281Antibody profiles characteristic of tuberculosis state
#282Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and
#283Fuidi herd management schema
#284Compositions and methods for immunodominant antigens of
#285Diagnostic mycobacterium tuberculosis test
#286Bioassay and peptides for use therein
#287Methods for producing an immune response to tuberculosis
#288Proteins expressed by and not by BCG and their use as diagnostic reagents and vaccines
#289METHOD AND COMPOSITIONS
#290Methods for detecting a infection
#291Method of Prognosis and/or Diagnosing an IRS in a Patient Infected with M. Tuberculosis and Optionally HIV
#292Fuidi herd management schema
#293Synthetic antigenic peptides and lipopeptides derived from subsp.
#294Antibody Profiles Characteristic of Tuberculosis State
#295TUBERCULOSIS ANTIGEN DETECTION ASSAYS AND VACCINES
#296Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
#297Effective new drug target for the treatment of tuberculosis
#298Compositions and methods for immunodominant antigens of
#299Solid support
#300Tuberculosis diagnostic test